Compare PROF & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | STRS |
|---|---|---|
| Founded | N/A | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.2M | 238.1M |
| IPO Year | 2017 | 1994 |
| Metric | PROF | STRS |
|---|---|---|
| Price | $6.92 | $28.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 61.0K | 29.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 512.50 |
| EPS | 0.19 | ★ 0.82 |
| Revenue | $16,098,000.00 | ★ $29,914,000.00 |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | $35.95 | ★ $35.49 |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $15.35 |
| 52 Week High | $8.95 | $32.93 |
| Indicator | PROF | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 42.23 |
| Support Level | $5.81 | $28.22 |
| Resistance Level | $7.07 | $31.62 |
| Average True Range (ATR) | 0.42 | 0.68 |
| MACD | -0.05 | -0.07 |
| Stochastic Oscillator | 19.09 | 37.35 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.